The prognostic value of systemic inflammatory response index (SIRI) in acute coronary syndrome patients treated with primary percutaneous coronary intervention: a meta-analysis and systematic review
Our meta-analysis demonstrates that an elevated SIRI is a useful predictor of all-cause mortality, MACE, new-onset AMI, and revascularization in patients with ACS undergoing PCI. As a simple and cost-effective index, SIRI shows significant potential for early risk stratification and may help guide clinical management in this patient population.
Authors
- Qianling Ye (ORCID: https://orcid.org/0000-0002-5651-2449)
- Francesco Paneni (ORCID: https://orcid.org/0000-0001-6483-7844)
- Christopher Dostal (ORCID: https://orcid.org/0000-0003-4961-6458)
- Matthias Ernst (ORCID: https://orcid.org/0000-0002-6399-1177)
- Gabor Tamas Szabó
- Chenming Hu
- P Pokreisz
- B Podesser
- Shunjie You
- Si Li
- Attila Kiss
Institutions
- University of Debrecen (HU)
- Affiliated Hospital of Southwest Medical University (CN)
- Meizhou City People's Hospital (CN)
- Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA (AT)
- University Hospital of Zurich (CH)
- Ludwig Boltzmann Institute for Age Research (AT)
- Ludwig Boltzmann Institute for Cancer Research (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2026-03-16
- DOI
- https://doi.org/10.1007/s00392-026-02889-4
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00